Nivolumab + Relatlimab

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Nivolumab nivolumab
Relatlimab relatlimab

Brands with this exact combination

Brand	Composition & strength	Manufacturer
OPDUALAGAU CA ES EU US	unknown ×2 Nivolumab + Relatlimab injection Nivolumab 12 mg + Relatlimab 4 mg liquid Nivolumab 12 mg/1 mL + Relatlimab 4 mg/1 mL injection Nivolumab 240 mg + Relatlimab 80 mg Other 1 compositions	BRISTOL-MYERS SQUIBB CANADA
nivolumab + relatlimabAU ES	240 mg / 80 mg / 240 mg/20 mL / 80 mg/20 mL	Bristol-Myers Squibb Australia Pty Ltd
nivolumab and relatlimab-rmbwUS	12 mg / 4 mg	E.R. Squibb & Sons, L.L.C.
Opdualag 240mg/20ml / 80mg/20ml concentrate for solution for infusion vialsGB	injection Nivolumab 240 mg/20 mL + Relatlimab 80 mg/20 mL	Bristol-Myers Squibb Pharmaceuticals Ltd
Nivolumab 240mg/20ml / Relatlimab 80mg/20ml solution for infusion vialsGB	240 mg/20 mL / 80 mg/20 mL	Bristol-Myers Squibb Pharmaceuticals Ltd
relatlimab + nivolumabAU	—	—
OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MGSG	injection Nivolumab + Relatlimab	BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
OPDUALAG nivolumab 240mg and relatlimab 80mg in 20mL concentrate solution for IV infusion vialAU	injection Nivolumab 255.6 mg + Relatlimab 85.2 mg	Bristol-Myers Squibb Australia Pty Ltd
OPDUALAG 240 mg/80 mg, solution à diluer pour perfusionFR	injection Nivolumab 12 mg/1 mL + Relatlimab 4 mg/1 mL	BRISTOL-MYERS SQUIBB / PFIZER EEIG (IRLANDE)

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.